Kestra Medical Technologies (KMTS) Return on Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.53%, changed N/A from the prior year.
• Return on Equity rose to 0.01% in Q1 2026 per KMTS's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Equity peaked at 0.04% in Q2 2025 and troughed at 0.01% in Q4 2025.
• A 3-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 1 bps in 2025 and fell as far as 1 bps in 2025.
• A 3-year view of Return on Equity shows it stood at 0.0% in 2024, then plunged by 1792 bps to 0.01% in 2025, then increased by 15 bps to 0.01% in 2026.
• Business Quant data shows KMTS's Return on Equity at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.